These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 1903998

  • 1. Assessment of tumour-infiltrating lymphocytes, regional lymph node lymphocytes and peripheral blood lymphocytes and their reaction to interferon-gamma in patients with renal carcinoma.
    Onishi T, Machida T, Masuda F, Hatano T, Shirakawa H, Natori T, Hamamoto M, Matsuoka Y.
    Br J Urol; 1991 May; 67(5):459-66. PubMed ID: 1903998
    [Abstract] [Full Text] [Related]

  • 2. [Immunological assessment of tumour infiltrating lymphocyte subsets in renal cell carcinoma patients. An analysis of immunological reaction to immuno-competent lymphocytes by interferon-gamma].
    Ohnishi T.
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):216-24. PubMed ID: 1904117
    [Abstract] [Full Text] [Related]

  • 3. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE, Van Gool SW, Van Poppel H, Baert L, Coorevits L, Van Damme B, Ceuppens JL.
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [Abstract] [Full Text] [Related]

  • 4. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL.
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [Abstract] [Full Text] [Related]

  • 5. Different immune functions of peripheral blood, regional lymph node, and tumor infiltrating lymphocytes in lung cancer patients.
    Nakamura H, Ishiguro K, Mori T.
    Cancer; 1988 Dec 15; 62(12):2489-97. PubMed ID: 3142676
    [Abstract] [Full Text] [Related]

  • 6. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma.
    Kowalczyk D, Skorupski W, Kwias Z, Nowak J.
    Br J Urol; 1997 Oct 15; 80(4):543-7. PubMed ID: 9352689
    [Abstract] [Full Text] [Related]

  • 7. Functional character and augmentation of lymphocytes in regional lymph nodes of patients with lung cancer.
    Watanabe Y, Hashizume Y, Shimizu J, Yoshida M, Watanabe S, Iwa T, Sakai S, Migita S, Sato H, Murayama T.
    Am Rev Respir Dis; 1990 Oct 15; 142(4):769-74. PubMed ID: 2221581
    [Abstract] [Full Text] [Related]

  • 8. [A study of effective administration of recombinant interferon-gamma in renal cell carcinoma regarding immunological influence on peripheral blood lymphocytes].
    Kawata N, Ono M, Kodama M, Yamanaka Y, Hirakata H, Hirano D, Fuse T, Takimoto Y.
    Hinyokika Kiyo; 1995 Jan 15; 41(1):21-6. PubMed ID: 7900565
    [Abstract] [Full Text] [Related]

  • 9. Effect of anti-CD3 antibody on the generation of interleukin-2-activated lymphocytes from tumor tissues of gastrointestinal cancer.
    Ohta T, Kikuchi H, Ogata H, Iwata K, Yoshida K, Katayama K, Watanabe H.
    Cancer; 1992 Aug 15; 70(4):741-8. PubMed ID: 1386555
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the immune reactivity of infiltrating and peripheral lymphocytes from patients with renal cell carcinoma by measuring cytokine secretion.
    Elsässer-Beile U, Wetterauer U, Schultze-Seemann W, Gallati H, Mönting JS, von Kleist S.
    Cancer Immunol Immunother; 1996 Feb 15; 42(2):93-8. PubMed ID: 8620526
    [Abstract] [Full Text] [Related]

  • 11. [Long-term immunological study on postoperative adjuvant treatment with interferon-gamma in patients with renal cell carcinoma who underwent nephrectomy].
    Miura H, Arai H, Matsuoka A, Yazawa K, Satoh E, Nishimura K, Honda M, Fujioka H.
    Hinyokika Kiyo; 1999 Feb 15; 45(2):79-83. PubMed ID: 10212778
    [Abstract] [Full Text] [Related]

  • 12. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
    Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman JJ, Smith CV, Pecorelli S, Radominska-Pandya A, Cannon MJ, Parham GP.
    Gynecol Obstet Invest; 2001 Feb 15; 51(4):254-61. PubMed ID: 11408737
    [Abstract] [Full Text] [Related]

  • 13. Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer.
    Takenoyama M, Yasumoto K, Harada M, Matsuzaki G, Ishida T, Sugimachi K, Nomoto K.
    Immunobiology; 1996 Jul 15; 195(2):140-51. PubMed ID: 8877391
    [Abstract] [Full Text] [Related]

  • 14. [Immunological assessment after radical nephrectomy for renal cell carcinomas pre-treated with interferon-gamma].
    Onishi T, Machida T, Masuda F, Igarashi H.
    Hinyokika Kiyo; 1991 Jul 15; 37(7):671-8. PubMed ID: 1927765
    [Abstract] [Full Text] [Related]

  • 15. Functional characterization of tumor-infiltrating lymphocytes, lymph-node lymphocytes and peripheral-blood lymphocytes from patients with breast cancer.
    Rubbert A, Manger B, Lang N, Kalden JR, Platzer E.
    Int J Cancer; 1991 Aug 19; 49(1):25-31. PubMed ID: 1908441
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
    Weidmann E, Logan TF, Yasumura S, Kirkwood JM, Trucco M, Whiteside TL.
    Cancer Res; 1993 Oct 15; 53(20):4745-9. PubMed ID: 8402652
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma.
    Pretscher D, Distel LV, Grabenbauer GG, Wittlinger M, Buettner M, Niedobitek G.
    BMC Cancer; 2009 Aug 22; 9():292. PubMed ID: 19698134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.